Semaglutide 5mg is a GLP-1 receptor agonist used in clinical settings for the management of type 2 diabetes. It is designed to support blood glucose regulation by enhancing insulin response and reducing post-meal glucose spikes.

This prescription-based therapy is widely studied in relation to metabolic health, glycemic control, and endocrine function within modern clinical research.